ASHLEY MCKEE: Open Payments
NPI 1447969969 · AUGUSTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$691 in 23 payments from 9 companies in 2025. Trend: 2023 $568 · 2024 $921 · 2025 $691
Food & beverage: $691
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 9 | $181 |
| Boston Scientific Corporation | 2 | $145 |
| AstraZeneca Pharmaceuticals LP | 1 | $111 |
| Actelion Pharmaceuticals US, Inc. | 3 | $94 |
| PFIZER INC. | 3 | $62 |
| Merck Sharp & Dohme LLC | 2 | $41 |
| CARDIVA MEDICAL, INC. | 1 | $22 |
| ABIOMED | 1 | $22 |
| HEARTFLOW, INC. | 1 | $15 |
Products named: LEQVIO, WATCHMAN FLX, LOKELMA, OPSYNVI, VYNDAQEL, VERQUVO, WATCHMAN Access System, OPSUMIT.
Industry payments across GA — which companies pay providers there.
